A Market Access track is in development.
Scoping is underway with access and pricing practitioners. Nothing is scheduled and no formats are on sale. Teams can register interest to help shape which workflows are built first.
This track is in development. No curriculum, dates, formats or pricing are available.
Works with enterprise-approved AI environments
- Microsoft Copilot
- ChatGPT
- Claude
- Gemini
- Internal & other approved AI
The same workflow method works across platforms. Your company’s tool, data-use and review policies remain the authority.
Who this track is built for
- Market access, pricing and HEOR teams exploring AI-assisted workflow support
- Access leads who want to influence which workflows are developed first
Candidate workflow areas under scoping
| Workflow chain | Named workflows included | What it helps teams do |
|---|---|---|
| Potential workflow areas under scoping | Payer environment scanning · Payer objection mapping · Value story stress-testing · HTA input synthesis · Country adaptation | Candidate areas only. Content, depth and sequencing are not finalised and no curriculum is available yet. |
Candidate areas only. Content, depth and sequencing are not finalised and no curriculum is available yet.
Built for governed pharma environments
- Public sessions use synthetic or anonymised PharmAI Pro case material. Participants do not bring company documents.
- Internal application happens only inside company-approved AI environments, under the company's own policies and controls.
- Only inputs permitted by company policy are used. Sensitive, patient-level, unpublished clinical and confidential commercial information stays out of scope.
- PharmAI Pro does not replace Medical, Legal, Regulatory, MLR, analytical validation, forecast governance or final business accountability.
Help shape which workflows are built first.
Register interest and we will come back when scoping is complete. Nothing is scheduled or on sale.